JP2024539123A5 - - Google Patents

Info

Publication number
JP2024539123A5
JP2024539123A5 JP2024523575A JP2024523575A JP2024539123A5 JP 2024539123 A5 JP2024539123 A5 JP 2024539123A5 JP 2024523575 A JP2024523575 A JP 2024523575A JP 2024523575 A JP2024523575 A JP 2024523575A JP 2024539123 A5 JP2024539123 A5 JP 2024539123A5
Authority
JP
Japan
Prior art keywords
aav
aavhu
aavrh
approximately
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523575A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024539123A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/060189 external-priority patent/WO2023073526A1/en
Publication of JP2024539123A publication Critical patent/JP2024539123A/ja
Publication of JP2024539123A5 publication Critical patent/JP2024539123A5/ja
Pending legal-status Critical Current

Links

JP2024523575A 2021-10-25 2022-10-24 アデノ随伴ウイルス(aav)送達を改善する方法 Pending JP2024539123A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163271487P 2021-10-25 2021-10-25
US63/271,487 2021-10-25
PCT/IB2022/060189 WO2023073526A1 (en) 2021-10-25 2022-10-24 Methods for improving adeno-associated virus (aav) delivery

Publications (2)

Publication Number Publication Date
JP2024539123A JP2024539123A (ja) 2024-10-28
JP2024539123A5 true JP2024539123A5 (cg-RX-API-DMAC7.html) 2025-10-31

Family

ID=84283163

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024523575A Pending JP2024539123A (ja) 2021-10-25 2022-10-24 アデノ随伴ウイルス(aav)送達を改善する方法

Country Status (5)

Country Link
US (1) US20250235554A1 (cg-RX-API-DMAC7.html)
EP (1) EP4422613A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024539123A (cg-RX-API-DMAC7.html)
CN (1) CN118043039A (cg-RX-API-DMAC7.html)
WO (1) WO2023073526A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024071362A1 (ja) * 2022-09-30 2024-04-04 国立大学法人東京医科歯科大学 神経系送達促進剤
WO2025101959A1 (en) * 2023-11-08 2025-05-15 Renbio, Inc. Plasmid dna constructs for peptide hormone expression
WO2025250454A1 (en) * 2024-05-28 2025-12-04 University Of Rochester Adeno-associated viruses evolved to specifically target human glial progenitor cells in vivo
CN118743768A (zh) * 2024-06-13 2024-10-08 浙江大学 一种血小板-aav包装复合体及其制备方法和应用
WO2026006766A1 (en) 2024-06-27 2026-01-02 Applied Cognition, Inc. Compositions, formulations, and methods of treating neurodegenerative diseases

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
WO1998033917A1 (en) 1994-11-14 1998-08-06 The Ludwig Institute For Cancer Research Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof
US6001650A (en) 1995-08-03 1999-12-14 Avigen, Inc. High-efficiency wild-type-free AAV helper functions
US6410300B1 (en) 1998-01-12 2002-06-25 The University Of North Carolina At Chapel Hill Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV
ES2932278T3 (es) 2004-06-01 2023-01-17 Genzyme Corp Composiciones y métodos para prevenir la agregación del vector AAV
PT2548560E (pt) 2005-06-23 2015-09-22 Isis Pharmaceuticals Inc Composições e métodos de modulação da excisão-união de smn2
US9415121B2 (en) 2008-12-19 2016-08-16 Nationwide Children's Hospital Delivery of MECP2 polynucleotide using recombinant AAV9
KR20220084437A (ko) 2009-06-17 2022-06-21 바이오젠 엠에이 인코포레이티드 대상에게서 smn2 스플라이싱을 조정하기 위한 조성물 및 방법
US9901650B2 (en) * 2013-02-21 2018-02-27 University Of Rochester Methods for evaluating brain-wide paravascular pathway for waste clearance function and methods for treating neurodegenerative disorders based thereon
RS63942B1 (sr) 2013-08-27 2023-02-28 Res Inst Nationwide Childrens Hospital Proizvodi i postupci za lečenje amiotrofične lateralne skleroze
EP3564379A1 (en) 2013-09-13 2019-11-06 California Institute of Technology Selective recovery
EP3632923A1 (en) 2015-01-16 2020-04-08 Voyager Therapeutics, Inc. Central nervous system targeting polynucleotides
AU2016366549B2 (en) 2015-12-11 2022-11-10 California Institute Of Technology Targeting peptides for directing adeno-associated viruses (AAVs)
EP4585229A3 (en) 2017-11-08 2026-01-14 Novartis AG Means and method for preparing viral vectors and uses of same
WO2019222329A1 (en) 2018-05-15 2019-11-21 Voyager Therapeutics, Inc. Compositions and methods for delivery of aav
WO2019222444A2 (en) 2018-05-16 2019-11-21 Voyager Therapeutics, Inc. Directed evolution
US20210207167A1 (en) 2018-05-16 2021-07-08 Voyager Therapeutics, Inc. Aav serotypes for brain specific payload delivery
EP3830107A2 (en) 2018-08-03 2021-06-09 Voyager Therapeutics, Inc. Aav variants with enhanced tropism
KR20210100086A (ko) * 2018-10-04 2021-08-13 유니버시티 오브 로체스터 혈장 오스몰농도 조작에 의한 글림프 전달의 개선

Similar Documents

Publication Publication Date Title
US20260139274A1 (en) Gene therapy for juvenile batten disease
US20240123003A1 (en) Gene therapies for lysosomal disorders
Huang et al. Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection
JP2020533959A5 (cg-RX-API-DMAC7.html)
JP6417322B2 (ja) 遺伝子治療ベクターの広範な遺伝子送達
JP2025179046A5 (cg-RX-API-DMAC7.html)
AU2023202598B2 (en) Intrathecal delivery of recombinant Adeno-associated virus encoding Methyl-CpG binding protein 2
JP2016514152A (ja) アデノ随伴ウイルスベクターおよびその使用の方法
JP2023514242A5 (cg-RX-API-DMAC7.html)
US12486518B2 (en) Bicistronic AAV vectors encoding hexosaminidase alpha and beta-subunits and uses thereof
US20230310654A1 (en) Gene therapies for lysosomal disorders
JP2024539123A (ja) アデノ随伴ウイルス(aav)送達を改善する方法
JP2025518052A (ja) Xlmtmを処置するための組成物
WO2025019295A2 (en) Renal pelvic injection for drug delivery to the kidney
JP2022545378A5 (cg-RX-API-DMAC7.html)
WO2023169115A1 (zh) 一种神经系统高亲和性的aav载体及其应用
JP2024530050A5 (cg-RX-API-DMAC7.html)
JP2025512709A5 (cg-RX-API-DMAC7.html)
JP2024515629A5 (cg-RX-API-DMAC7.html)
US20250250566A1 (en) Gene silencing by recombinant aav-amirna in alexander disease
JP2025510150A5 (cg-RX-API-DMAC7.html)
TW202432190A (zh) 投藥途徑
WO2025157137A1 (zh) Aav载体、载体组合物、嵌合载体和治疗或预防sma的方法
TW202434729A (zh) 含有星狀細胞導向啟動子構築體之合成核酸及其使用方法
JP2024515623A (ja) 髄腔内送達によってピット・ホプキンス症候群を治療するためのメチル-cpg結合タンパク質2をコードする組換えアデノ随伴ウイルス